The highest SLFN-11 expression level was found in MDA-MB-468 triple-negative breast cancer (TNBC) cells, which was more than 10-fold higher compared to MCF-7 hormone receptor-positive (HR+) breast cancer cells and at least 300-fold higher compared to the other breast (cancer) cell lines. This evidence concerns the gene NR4A1 and breast carcinoma.